Interferon Alpha Carrier Prodrugs
AssigneeAscendis Pharma AS
InventorsHarald Rau, Silvia Kaden-Vagt
Life of this patent
Estimating the term…
Abstract
The present invention relates to a pharmaceutical composition comprising a water-soluble polymeric carrier linked prodrug of interferon alpha, wherein the prodrug is capable of releasing free interferon alpha, wherein the release half life under physiological conditions is at least 4 days. The invention further relates to prodrugs for said pharmaceutical composition and their use for treating, controlling, delaying or preventing a condition that can benefit from interferon alpha treatment, such as hepatitis C.
Claims42
A pharmaceutical composition comprising a water-soluble polymeric carrier linked prodrug of interferon alpha, wherein the prodrug is capable of releasing free interferon alpha, wherein the release half life under physiological conditions is at least 4 days.
Dependencies are inferred from the claim text.